[Federal Register Volume 60, Number 29 (Monday, February 13, 1995)]
[Notices]
[Page 8251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-3456]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration
[DEA No. 129P]


Proposed 1995 Aggregate Production Quota for a Schedule II 
Controlled Substance

AGENCY: Drug Enforcement Administration.

ACTION: Notice of a proposed 1995 aggregate production quota.

-----------------------------------------------------------------------

SUMMARY: This notice proposes a 1995 aggregate production quota for 
hydrocodone (for conversion), a controlled substance in Schedule II of 
the Controlled Substances Act (CSA).

DATES: Comments or objections must be received on or before March 15, 
1995.

ADDRESSES: Send comments or objections to the Administrator, Drug 
Enforcement Administration, Washington, DC 20537, Attn: DEA Federal 
Register Representative/CCR.

FOR FURTHER INFORMATION CONTACT:
Howard McClain, Jr., Chief, Drug & Chemical Evaluation Section, Drug 
Enforcement Administration, Washington, DC 20537, Telephone: (202) 307-
7183.

SUPPLEMENTARY INFORMATION: Section 306 of the Controlled Substances Act 
(CSA) (21 U.S.C. 826) requires that the Attorney General establish 
aggregate production quotas for controlled substances in Schedules I 
and II each year. This responsibility has been delegated to the 
Administrator of the DEA pursuant to Section 0.100 of Title 28 of the 
Code of Federal Regulations.
    The Administrator, in turn, has redelegated this function to the 
Deputy Administrator pursuant to 59 FR 23637 (May 6, 1994).
    A company submitted an application for a manufacturing quota for 
hydrocodone (for conversion) a Schedule II controlled substance. Based 
on the review of this application and other information available to 
the DEA, the Deputy Administrator of the DEA, under the authority 
vested in the Attorney General by Section 306 of the Controlled 
Substances Act of 1970 (21 U.S.C. 826), delegated to the Administrator 
by Section 0.100 of Title 28 of the Code of Federal Regulations, and 
redelegated to the Deputy Administrator pursuant to 59 FR 23637 (May 6, 
1994), hereby proposes that the 1995 aggregate production quota for the 
following controlled substance, expressed in grams of anhydrous base, 
be established as follows:

------------------------------------------------------------------------
                                                               Proposed 
                                                                 1995   
                                                              aggregate 
                        Basic class                           production
                                                                quota   
                                                               (grams)  
------------------------------------------------------------------------
Hydrocodone (for conversion)...............................    2,200,000
------------------------------------------------------------------------

    All interested persons are invited to submit comments or 
objections, in writing, regarding this proposal. If a person believes 
that one or more of these issues warrant a hearing, the individual 
should so state and summarize the reasons for this belief.
    In the event that comments or objections to this proposal raise one 
or more issues which the Administrator finds warrant a hearing, the 
Administrator shall order a public hearing by notice in the Federal 
Register, summarizing the issues to be heard and setting the time for 
the hearing.
    The Office of Management and Budget has determined that notices of 
aggregate production quotas are not subject to centralized review under 
Executive Order 12866.
    This action has been analyzed in accordance with the principles and 
criteria contained in the Executive Order 12612 and it has been 
determined that this matter does not have sufficient federalism 
implications to warrant the preparation of a Federalism Assessment.
    The Deputy Administrator hereby certifies that this action will 
have no significant impact upon small entities within the meaning of 
and intent of the Regulatory Flexibility Act, 5 U.S.C., 601, et seq. 
The establishment of annual aggregate production quotas for Schedules I 
and II controlled substances is mandated by law and by international 
treaty obligations. While aggregate production quotas are of primary 
importance to large manufacturers, their impact upon small entities is 
neither negative nor beneficial. Accordingly, the Deputy Administrator 
has determined that this action does not require a regulatory 
flexibility analysis.

    Dated: February 6, 1995.
Stephen H. Green,
Deputy Administrator.
[FR Doc. 95-3456 Filed 2-10-95; 8:45 am]
BILLING CODE 4410-09-M